secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indaptus Therapeutics, Inc. (INDP)
CIK:        0001857044
Form:       8-K
Filed at:   2023-02-14T23:59:59+00:00
Accession:  0001493152-23-004613
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Indaptus appoints Robert Martell, M.D., Ph.D. to Board of Directors
-------------------------------------------------------------------

- Board size increased to nine; Martell appointed Class I director effective Feb 13, 2023.
- Annual retainer of $50,000 for Board service; standard indemnification agreement.
- Received initial option for 20,000 shares at $1.71/share (fair market value on grant date).
- Annual equity award up to $75,000 value (Black-Scholes) vesting on first anniversary or upon change of control.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1857044/000149315223004613/0001493152-23-004613-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1857044/000149315223004613/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-004613

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer